ShareProphets : tidm

CMCX

CMC Markets (#CMCX) – H1 EPS +6%, DPS maintained, argues strategic growth plans “on track”

2022-11-16 07:23:25

CMC Markets (#CMCX) – H1 net operating income +21% YoY, closed with pickup in market volatility and client trading volumes

2022-10-06 07:26:10

CMC Markets (#CMCX) – net operating income currently in-line with prior year, operating costs above guidance

2022-07-28 07:23:45

CMC Markets (#CMCX) – FY EPS down to 24.8p, DPS 12.38p, notes a lot of macro uncertainty

2022-06-09 07:22:27

CMC Markets full year results come in at the top end of guidance and there's a large share buyback in progress - do you buy more shares?

The performance of CMC Markets (CMCX) has been pretty disappointing in recent times, but now there are some signs of its financial performance improving and a potential demerging of the business on the horizon.

By Gary Newman | Published 2022-04-11 08:19:33 |

CMC Markets (#CMCX) – Q4 “strongest quarter of the year”, notes strategy expansion

2022-04-08 07:24:17

CMC Markets should be starting to benefit from increased volatility and is too cheap - recovery buy

I always find it hard to buy shares where I see fundamental good value and where I am intending to hold them as an actual investment rather than just a short term trade based on momentum.

By Gary Newman | Published 2022-01-22 14:24:59 |

CMC Markets (#CMCX) – H1 EPS -75%, +1% on 2 year basis, DPS 3.5p

2021-11-17 07:20:30

CMC Markets (#CMCX) – confirms evaluating separation of leveraged and non-leveraged divisions

2021-11-15 07:22:27

CMC Markets (#CMCX) – H1 net operating income c. £126m, reiterates FY guidance of £250-280m

2021-10-07 07:43:00

I expect higher market volatility in the coming months and CMC Markets will benefit from that - buy the recent weakness

Recently the markets have been strong and generally have been heading in an upwards direction, which has been great news for many investors holding shares in larger FTSE companies.

By Gary Newman | Published 2021-09-08 12:57:25 |

CMC Markets (#CMCX) – lower trading activity, now expects FY net operating income £250m-£280m

2021-09-02 07:23:18

CMC Markets (#CMCX) – “active client numbers remain at similar levels”, trading activity has moderated

2021-07-29 07:30:55

CMC Markets (#CMCX) – FY EPS & DPS +104%, client trading activity now “has moderated”

2021-06-10 07:24:21

CMC Markets (#CMCX) – FY net operating income now expected to be “slightly ahead of” £399.6m

2021-03-25 07:19:11

CMC Markets (#CMCX) – Q3 update, confident that FY net operating income will be “at the upper end of the current market consensus”

2021-01-20 07:18:02

CMC Markets (#CMCX) – H1 net operating income +126%, EPS +303%, DPS +223%

2020-11-19 07:13:48

CMC Markets (#CMCX) – “record first half performance”, argues “many opportunities… to expand our product portfolio and deliver further diversification”

2020-10-08 07:23:07

CMC Markets (#CMCX) – “strong trading performance across the business has continued”

2020-09-03 07:32:44

CMC Markets (#CMCX) – “net operating income for Q1 2021 is in excess of that reported for H1 2020 of £102.3 million”

2020-07-03 07:10:45

previous 20 Page 2 of 3 (60 articles) next 20

Latest News

Show All

UPDATED: Lucian Miers & Jim Mellon are coming back to Sharestock in 2027: early bird tickets now on sale, event 15% sold out!

Tom Winnifrith Bearcast: the Sydney Sweeney row with the Mrs and daughter 2

Evil Banksta weighs in on TekCapital after today’s spooftastic RNS

Good news travels fast but bad news….the case of Skinbiotherapeutics

Mothercare: the end is nigh, don’t blame Trump, I told y’all eons ago

EXPOSE: Nuburu shares in a slump post relisting on American Stock Exchange and latest accounts contain a material error

Letter to Pointon Young, former auditors to Amazing AI

Reinvesting my Satsuma Winnings

Tribal Group – “Proposed Acquisition by Main Capital Partners” provides us with another share tip winner

Quantum Data Energy - why are its shares still suspended?

Recent Comments

TOM18 Sep 2026

a shareholder could call a meeting to propose new directors by PM & pals own 50% of the equity sod vote it down

Letter to Pointon Young, former auditors to Amazing AI

AIMINVESTOR18 Sep 2026

This makes a mockery of the the so called rules and regulations when something as blatant as this is done.It's a shame a shareholder can't propose themselves as a director just to prevent the strike-off.Is there nothing legal that can be done at this point?

Letter to Pointon Young, former auditors to Amazing AI

TOYIN18 Sep 2026

Thanks Tom, just picked some more up sub 8p.

Good news travels fast but bad news….the case of Skinbiotherapeutics

JOHN BROWN18 Sep 2026

It's outrageous that the likes of Amy Hunt claim that women with Sydney Sweeney's body shape cannot play sport. Who said that sportswomen can't look like Ms Sweeney?

Tom Winnifrith Bearcast: the Sydney Sweeney row with the Mrs and daughter 2

MICKTHELINGE18 Sep 2026

If it gets to 3p then construction will be going well and it will be well on the way to 6p+ so interested in why you would sell out then?

Reinvesting my Satsuma Winnings

TOM18 Sep 2026

Whatever Opti's intentions it will have to sell.You could say you should sell now as maybe your last chance to sell at above 8oops too late, now 7.5p to sell

Good news travels fast but bad news….the case of Skinbiotherapeutics

DUCKnDIVE18 Sep 2026

I thought that a seasoned reader of financial statements would have clocked that OPTI's HY results to 30/6/26 classed their SBTX shares as non-current assets – meaning that management has no intention to sell them within 12 months.Maybe you assumed that they were forced to class them as non-current because SBTX shares were suspended…but no, the SBTX suspension was lifted weeks before OPTI's sign-off date.And if you believe that OPTI haven't sold all or most of their remaining SBTX shares since June 30th, I'm afraid they saw you coming.There is of course a risk that OPTI has double accounted for its SBTX shares, having included them in both non-current assets and in "cash and equivalents", which might be a fruitful line of enquiry for you.As for Skin's RNS arriving a day outside the standard 10th-20th definition of mid-month, they have had a lot of balls to juggle so a 24hr delay ought to be a cause for congratulations.Why not grab some SBTX shares this afternoon? Could be your last chance to buy back below 12p.

Good news travels fast but bad news….the case of Skinbiotherapeutics

DUCKnDIVE18 Sep 2026

Notwithstanding your ad nauseam negativity on SBTX, I choose to believe the positive indications from the 8 June RNS, including "Growth continued across the company", under Current Trading and Outlook (from a chairman who never speaks with forked tongue). Accordingly, I have helped myself to a nice top-up in anticipation of a welcome trading update on Monday.

Tom Winnifrith Bearcast: Hang on for the PS in the podcast